Proper use of neuromuscular blocking agents by the anesthesiologist, emergency department physician, intensivist, anesthesia nurse, and critical care specialists is paramount. Residual neuromuscular weakness is recognizedÂ as a common problem in the post-anesthesia care unit (PACU), where at least 20 to 40% of patients can be shown to have objective evidence of residual weakness.